Shingles (Herpes Zoster): Vaccine for a Healthy Future

Shingles (Herpes Zoster): Vaccine for a Healthy Future


Identification: AMBJ1304
Issue: July/August 2013
Credits (Post Test and/or Evaluation Required)
Available until 08/31/2015
  • 1.30 - CH
  • 0.00 - Rx


Description

Contact hours available until 8/31/2015.


Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.


Faculty, Planners and Authors Conflict of Interest Disclosure:
The author, editor, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.


Commercial Support and Sponsorship:
No commercial support or sponsorship declared.


Accreditation Statement:

This educational activity has been co-provided by Anthony J. Jannetti, Inc. and AAACN.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

AAACN is a provider approved by the California Board of Registered Nursing, provider number CEP 5366.


Objectives:

  • Discuss the three most common symptoms seen in the early stage of the shingles process.
  • Identify the single most common long-term complication related to shingles disease.
  • Describe one Medicare guideline related to cost coverage of shingles vaccine.
  • Explain importance of shingles vaccine storage and administration techniques.

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.